file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
201 | SUCCESSFUL | 19 | 110 | 467 |
202 | PERSISTENCE | 11 | 109 | 263 |
203 | POLYMERASE | 16 | 108 | 238 |
204 | BROWN-NORWAY | 1 | 105 | 167 |
205 | GRAFT-VERUS-HOST | 1 | 105 | 167 |
206 | KINDS | 1 | 105 | 167 |
207 | RAPAMYCIN | 25 | 105 | 1906 |
208 | SUPPRESSION | 23 | 105 | 896 |
209 | MONITORING | 33 | 104 | 880 |
210 | REGENERATION | 18 | 102 | 894 |
211 | RESULTS | 40 | 102 | 1177 |
212 | SERA | 19 | 101 | 466 |
213 | MONKEY | 4 | 100 | 261 |
214 | TREATED | 30 | 100 | 1243 |
215 | HEART-TRANSPLANTATION | 5 | 99 | 141 |
216 | INHIBITION | 38 | 99 | 1265 |
217 | CHORD | 1 | 98 | 188 |
218 | HEMATOLYMPHOID | 3 | 98 | 150 |
219 | INFUSIONS | 7 | 98 | 199 |
220 | LOST | 2 | 98 | 191 |
221 | NOVEL | 29 | 98 | 1195 |
222 | SPONTANEOUSLY | 6 | 98 | 291 |
223 | ACTIVITY | 34 | 97 | 959 |
224 | GAUCHERS-DISEASE | 1 | 97 | 162 |
225 | GLYCOGEN-STORAGE-DISEASE | 1 | 97 | 162 |
226 | MODEL | 55 | 97 | 752 |
227 | RESPONSES | 29 | 97 | 501 |
228 | TYPE-IV | 1 | 97 | 162 |
229 | MOUSE | 16 | 96 | 452 |
230 | MAINTENANCE | 11 | 95 | 306 |
# | Word | Recs | TLCS | TGCS |
231 | PLASMA | 24 | 95 | 732 |
232 | TISSUES | 8 | 95 | 325 |
233 | TRAFFICKING | 2 | 95 | 130 |
234 | ANTIBODY | 34 | 94 | 612 |
235 | GVH | 3 | 94 | 139 |
236 | INDUCE | 15 | 94 | 521 |
237 | LIGANDS | 8 | 93 | 1524 |
238 | SYNERGISM | 2 | 93 | 193 |
239 | HISTOCOMPATIBILITY | 19 | 92 | 401 |
240 | OBSERVATIONS | 17 | 92 | 700 |
241 | LIGAND | 11 | 91 | 915 |
242 | PROPAGATION | 5 | 91 | 329 |
243 | TISSUE | 42 | 91 | 1117 |
244 | STATUS | 27 | 90 | 678 |
245 | LIVING-RELATED | 16 | 89 | 507 |
246 | PROLONG | 7 | 89 | 478 |
247 | REACTIVITY | 15 | 89 | 666 |
248 | STEM | 27 | 89 | 536 |
249 | ACCEPTED | 7 | 88 | 267 |
250 | DOG | 10 | 88 | 331 |
251 | WHOLE | 5 | 88 | 193 |
252 | ESSENTIAL | 4 | 87 | 213 |
253 | APOPTOSIS | 13 | 85 | 393 |
254 | TRANSFUSION | 22 | 85 | 580 |
255 | ACTION | 25 | 84 | 923 |
256 | HYPERACUTE | 7 | 84 | 722 |
257 | NERVE | 20 | 84 | 675 |
258 | SIMULTANEOUS | 22 | 84 | 318 |
259 | COMPOSITE | 28 | 82 | 461 |
260 | MOUSE-LIVER | 3 | 82 | 295 |
# | Word | Recs | TLCS | TGCS |
261 | DIM | 2 | 81 | 445 |
262 | EVOLUTION | 11 | 81 | 987 |
263 | GROWTH | 11 | 81 | 288 |
264 | TOLERANT | 10 | 81 | 250 |
265 | EXPERIMENTAL | 44 | 80 | 931 |
266 | LEUKOCYTE | 17 | 80 | 279 |
267 | REPORT | 21 | 80 | 491 |
268 | CYTOKINE | 18 | 79 | 532 |
269 | MECHANISM | 23 | 79 | 787 |
270 | PROLONGATION | 21 | 79 | 410 |
271 | EFFICACY | 26 | 78 | 671 |
272 | T-CELL | 34 | 78 | 1231 |
273 | DETECTION | 23 | 77 | 688 |
274 | HOST | 28 | 77 | 544 |
275 | KIDNEY-TRANSPLANT | 5 | 77 | 405 |
276 | LEVELS | 18 | 77 | 517 |
277 | SINGLE | 14 | 77 | 1091 |
278 | TRIALS | 6 | 77 | 325 |
279 | ABDOMINAL | 6 | 76 | 560 |
280 | MONOTHERAPY | 18 | 75 | 491 |
281 | REACTION | 23 | 75 | 327 |
282 | MARROW-DERIVED | 7 | 74 | 334 |
283 | PRODUCTION | 28 | 74 | 703 |
284 | AZATHIOPRINE | 36 | 73 | 739 |
285 | DOGS | 14 | 73 | 626 |
286 | CHEMISTRY | 3 | 72 | 1381 |
287 | DETERMINING | 1 | 72 | 227 |
288 | IMMUNOPHILINS | 5 | 72 | 1525 |
289 | NORMAL | 13 | 72 | 344 |
290 | SHORT-AND | 1 | 72 | 227 |
# | Word | Recs | TLCS | TGCS |
291 | COMPARING | 9 | 71 | 597 |
292 | DRUG-THERAPY | 3 | 71 | 1612 |
293 | ALG | 9 | 70 | 333 |
294 | ANTI-THYMOCYTE | 10 | 70 | 359 |
295 | CURRENT | 45 | 70 | 993 |
296 | CHARACTERIZATION | 13 | 69 | 411 |
297 | CHILDREN | 30 | 69 | 771 |
298 | CYCLOSPORINE-TREATED | 8 | 69 | 538 |
299 | IMMUNOLOGICAL | 34 | 69 | 535 |
300 | METABOLISM | 20 | 69 | 842 |
301 | ANTI-LYMPHOCYTE | 17 | 68 | 445 |
302 | ANTILYMPHOCYTIC | 17 | 68 | 368 |
303 | CLONAL | 5 | 68 | 397 |
304 | ASSESSMENT | 14 | 67 | 319 |
305 | POSTTRANSPLANT | 15 | 67 | 495 |
306 | ADMINISTRATION | 28 | 66 | 483 |
307 | CHIMERIC | 11 | 66 | 158 |
308 | CYCLOSPORINE-RELATED | 1 | 66 | 113 |
309 | DOSE | 20 | 66 | 529 |
310 | EXPRESSION | 27 | 66 | 761 |
311 | MEASUREMENT | 7 | 66 | 278 |
312 | MECHANISMS | 33 | 66 | 823 |
313 | RAT-LIVER | 2 | 66 | 121 |
314 | MANAGEMENT | 28 | 64 | 762 |
315 | PANCREATIC | 9 | 64 | 397 |
316 | SIGNIFICANCE | 11 | 64 | 343 |
317 | UNRESPONSIVENESS | 9 | 64 | 247 |
318 | EPISODES | 9 | 63 | 274 |
319 | ESTABLISHED | 9 | 63 | 131 |
320 | IN-VITRO | 15 | 63 | 403 |
# | Word | Recs | TLCS | TGCS |
321 | MULTILINEAGE | 5 | 63 | 92 |
322 | POTENTIAL | 15 | 63 | 584 |
323 | VITRO | 20 | 63 | 571 |
324 | CORRELATIONS | 3 | 62 | 117 |
325 | RISK-FACTORS | 7 | 62 | 627 |
326 | LATE | 11 | 61 | 319 |
327 | USED | 16 | 61 | 337 |
328 | COMPARED | 8 | 60 | 168 |
329 | LOW-DOSE | 13 | 60 | 381 |
330 | PROLONGED | 16 | 60 | 242 |
331 | XENOTRANSPLANTATION | 28 | 60 | 480 |
332 | BIOLOGY | 5 | 59 | 1242 |
333 | CHAIN-REACTION | 7 | 59 | 115 |
334 | FLOW | 14 | 59 | 216 |
335 | IDENTIFICATION | 16 | 59 | 454 |
336 | ISOLATION | 9 | 59 | 291 |
337 | METABOLITES | 6 | 59 | 397 |
338 | STABILITY | 1 | 59 | 87 |
339 | THYMOGLOBULIN | 8 | 59 | 376 |
340 | GRAFTING | 7 | 58 | 281 |
341 | INFLUENCE | 28 | 58 | 401 |
342 | ACTIVATION | 17 | 57 | 615 |
343 | ANERGY | 3 | 57 | 322 |
344 | INCREASES | 7 | 57 | 443 |
345 | SEROLOGIC | 5 | 57 | 218 |
346 | HYPORESPONSIVENESS | 10 | 56 | 397 |
347 | STEROID-THERAPY | 3 | 56 | 362 |
348 | GINGIVAL | 24 | 55 | 691 |
349 | INSULIN | 9 | 55 | 388 |
350 | MULTICENTER | 10 | 55 | 371 |
# | Word | Recs | TLCS | TGCS |
351 | PREPARATION | 14 | 55 | 342 |
352 | SINGLE-CENTER | 12 | 55 | 430 |
353 | VASCULARIZED | 19 | 55 | 208 |
354 | ASSAYS | 7 | 54 | 161 |
355 | CYCLOSPORINE-A | 28 | 54 | 872 |
356 | FOLLOW-UP | 22 | 54 | 353 |
357 | INJURY | 22 | 54 | 673 |
358 | LONG | 7 | 54 | 690 |
359 | RELEVANCE | 3 | 54 | 105 |
360 | COLLAGEN | 1 | 53 | 207 |
361 | GRANULOCYTE-MACROPHAGE | 2 | 53 | 212 |
362 | IMMUNOPHILIN | 5 | 53 | 750 |
363 | MATURATIONAL | 1 | 53 | 207 |
364 | PROPERTIES | 13 | 53 | 278 |
365 | SIGNAL | 5 | 53 | 826 |
366 | CONCENTRATIONS | 10 | 52 | 257 |
367 | EVALUATION | 26 | 52 | 605 |
368 | HLA | 9 | 52 | 230 |
369 | IMPACT | 18 | 52 | 612 |
370 | RATE | 6 | 52 | 409 |
371 | APPROACH | 12 | 51 | 234 |
372 | DELAYED | 7 | 51 | 267 |
373 | REGULATION | 15 | 51 | 402 |
374 | DEFINING | 1 | 50 | 129 |
375 | ENGRAFTMENT | 16 | 50 | 172 |
376 | LINKED | 1 | 50 | 138 |
377 | NATURAL | 21 | 50 | 394 |
378 | T-LYMPHOCYTE | 2 | 50 | 198 |
379 | TROUGH | 2 | 50 | 166 |
380 | ANTI-CD4 | 2 | 49 | 150 |
# | Word | Recs | TLCS | TGCS |
381 | CHAIN | 9 | 49 | 123 |
382 | CONSECUTIVE | 8 | 49 | 214 |
383 | LYMPHOID-TISSUES | 2 | 49 | 75 |
384 | MATERNAL | 7 | 49 | 1020 |
385 | PCR | 11 | 49 | 100 |
386 | PLUS | 6 | 49 | 225 |
387 | PRIMARY-TREATMENT | 1 | 49 | 92 |
388 | RELATED | 23 | 49 | 615 |
389 | RENAL-ALLOGRAFTS | 14 | 49 | 310 |
390 | AGENT | 17 | 48 | 652 |
391 | ANTILYMPHOBLAST | 7 | 48 | 208 |
392 | ATG | 9 | 48 | 159 |
393 | COMBINATION | 17 | 48 | 582 |
394 | FKBP | 6 | 48 | 829 |
395 | PERSPECTIVES | 12 | 48 | 313 |
396 | SYNGENEIC | 6 | 48 | 296 |
397 | CD86 | 2 | 47 | 288 |
398 | CORRELATES | 10 | 47 | 258 |
399 | LIVER-MICROSOMES | 5 | 47 | 195 |
400 | OPTIMAL | 6 | 47 | 176 |